1-56674397-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_006252.4(PRKAA2):āc.111A>Gā(p.Leu37Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0336 in 1,559,532 control chromosomes in the GnomAD database, including 1,066 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.025 ( 71 hom., cov: 33)
Exomes š: 0.035 ( 995 hom. )
Consequence
PRKAA2
NM_006252.4 synonymous
NM_006252.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.48
Genes affected
PRKAA2 (HGNC:9377): (protein kinase AMP-activated catalytic subunit alpha 2) The protein encoded by this gene is a catalytic subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. Studies of the mouse counterpart suggest that this catalytic subunit may control whole-body insulin sensitivity and is necessary for maintaining myocardial energy homeostasis during ischemia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 1-56674397-A-G is Benign according to our data. Variant chr1-56674397-A-G is described in ClinVar as [Benign]. Clinvar id is 3056337.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=1.48 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0249 (3790/152196) while in subpopulation NFE AF= 0.0372 (2529/67954). AF 95% confidence interval is 0.036. There are 71 homozygotes in gnomad4. There are 1840 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 3790 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKAA2 | NM_006252.4 | c.111A>G | p.Leu37Leu | synonymous_variant | 2/9 | ENST00000371244.9 | NP_006243.2 | |
PRKAA2 | XM_017001693.2 | c.-160A>G | 5_prime_UTR_premature_start_codon_gain_variant | 2/9 | XP_016857182.1 | |||
PRKAA2 | XM_017001693.2 | c.-160A>G | 5_prime_UTR_variant | 2/9 | XP_016857182.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRKAA2 | ENST00000371244.9 | c.111A>G | p.Leu37Leu | synonymous_variant | 2/9 | 1 | NM_006252.4 | ENSP00000360290.4 |
Frequencies
GnomAD3 genomes AF: 0.0249 AC: 3792AN: 152078Hom.: 71 Cov.: 33
GnomAD3 genomes
AF:
AC:
3792
AN:
152078
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0268 AC: 5591AN: 208508Hom.: 96 AF XY: 0.0278 AC XY: 3165AN XY: 113962
GnomAD3 exomes
AF:
AC:
5591
AN:
208508
Hom.:
AF XY:
AC XY:
3165
AN XY:
113962
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0345 AC: 48595AN: 1407336Hom.: 995 Cov.: 30 AF XY: 0.0342 AC XY: 23900AN XY: 699300
GnomAD4 exome
AF:
AC:
48595
AN:
1407336
Hom.:
Cov.:
30
AF XY:
AC XY:
23900
AN XY:
699300
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0249 AC: 3790AN: 152196Hom.: 71 Cov.: 33 AF XY: 0.0247 AC XY: 1840AN XY: 74422
GnomAD4 genome
AF:
AC:
3790
AN:
152196
Hom.:
Cov.:
33
AF XY:
AC XY:
1840
AN XY:
74422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
27
AN:
3464
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PRKAA2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 13, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at